Table 7 Covid-19 vaccines used in office workers and seafarers.

From: Psychosocial burden, vaccination status and preventive information options for seafarers during the COVID-19 pandemic

COVID-19 vaccines

Office workers

(n doses = 62)

Seafarers

(n doses = 830)

Comirnaty (BioNTech/Pfizer)

37 (60%)

277 (33.4%)

Spikevax (Moderna)

17 (27.4%)

131 (15.6%)

Janssen (Johnson & Johnson)

4 (6.5%)

128 (15.4%)

Sinopharm

0

119 (14.3%)

CoronaVac

0

87 (10.5%)

Vaxzervria (AstraZeneca)

4 (6.5%)

55 (6.6%)

Sputnik

0

19 (2.3%)

Covishield

0

14 (1.7%)

Back to article page